CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. Strategic acquisition under CBC's buyout strategy...